BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18801826)

  • 21. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state.
    Yang CW; Lu C; Wu CC; Wen SC
    Am J Emerg Med; 2012 Jun; 30(5):833.e1-2. PubMed ID: 21514763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine-induced hyperglycemic hyperosmolar nonketotic coma: a case report.
    McCall M; Bourgeois JA
    J Clin Psychopharmacol; 2004 Dec; 24(6):670-3. PubMed ID: 15538133
    [No Abstract]   [Full Text] [Related]  

  • 25. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone].
    López-Torres E; Cobo I; Lucena MI
    Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786
    [No Abstract]   [Full Text] [Related]  

  • 26. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB; Stark JE
    Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K; Leinonen E
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.
    Moreno JL; Palau Fayos JM; Díaz de Santiago A; García de Yébenes J
    J Huntingtons Dis; 2012; 1(1):31-2. PubMed ID: 25063189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of olanzapine in adolescent with bipolar disorder after neuroleptic malignant syndrome].
    Boarati MA; Fu-I L
    Braz J Psychiatry; 2008 Mar; 30(1):86. PubMed ID: 18373024
    [No Abstract]   [Full Text] [Related]  

  • 32. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
    Gheorghiu S; Knobler HY; Drumer D
    Am J Psychiatry; 1999 Nov; 156(11):1836. PubMed ID: 10553758
    [No Abstract]   [Full Text] [Related]  

  • 34. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
    Abu-Kishk I; Toledano M; Reis A; Daniel D; Berkovitch M
    J Toxicol Clin Toxicol; 2004; 42(6):921-5. PubMed ID: 15533033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unrecognised case of withdrawal neuroleptic malignant syndrome: a case report.
    Ball H; de Waal H; Craig K
    Med Sci Law; 2009 Oct; 49(4):298-300. PubMed ID: 20025106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intensive care treatment for neuroleptic malignant syndrome].
    Hensel M; Böhler K; Marnitz R; Binder C; von Brevern M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jul; 45(7-8):448-55. PubMed ID: 20665353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
    Belvederi Murri M; Guaglianone A; Bugliani M; Calcagno P; Respino M; Serafini G; Innamorati M; Pompili M; Amore M
    Drugs R D; 2015 Mar; 15(1):45-62. PubMed ID: 25578944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole.
    Campanella LM; Lartey R; Shih R
    Ann Emerg Med; 2009 Feb; 53(2):264-6. PubMed ID: 18468728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.